Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts.

van der Heijden M, Miedema DM, Waclaw B, Veenstra VL, Lecca MC, Nijman LE, van Dijk E, van Neerven SM, Lodestijn SC, Lenos KJ, de Groot NE, Prasetyanti PR, Arricibita Varea A, Winton DJ, Medema JP, Morrissey E, Ylstra B, Nowak MA, Bijlsma MF, Vermeulen L.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6140-6145. doi: 10.1073/pnas.1813417116. Epub 2019 Mar 8.

2.

Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.

Prasetyanti PR, van Hooff SR, van Herwaarden T, de Vries N, Kalloe K, Rodermond H, van Leersum R, de Jong JH, Franitza M, Nürnberg P, Todaro M, Stassi G, Medema JP.

Int J Cancer. 2019 Jan 15;144(2):366-371. doi: 10.1002/ijc.31767. Epub 2018 Oct 22.

PMID:
30151914
3.

Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.

Linnekamp JF, Hooff SRV, Prasetyanti PR, Kandimalla R, Buikhuisen JY, Fessler E, Ramesh P, Lee KAST, Bochove GGW, de Jong JH, Cameron K, Leersum RV, Rodermond HM, Franitza M, Nürnberg P, Mangiapane LR, Wang X, Clevers H, Vermeulen L, Stassi G, Medema JP.

Cell Death Differ. 2018 Mar;25(3):616-633. doi: 10.1038/s41418-017-0011-5. Epub 2018 Jan 5.

4.

Intra-tumor heterogeneity from a cancer stem cell perspective.

Prasetyanti PR, Medema JP.

Mol Cancer. 2017 Feb 16;16(1):41. doi: 10.1186/s12943-017-0600-4. Review.

5.

TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.

Fessler E, Drost J, van Hooff SR, Linnekamp JF, Wang X, Jansen M, De Sousa E Melo F, Prasetyanti PR, IJspeert JE, Franitza M, Nürnberg P, van Noesel CJ, Dekker E, Vermeulen L, Clevers H, Medema JP.

EMBO Mol Med. 2016 Jul 1;8(7):745-60. doi: 10.15252/emmm.201606184. Print 2016 Jul.

6.

A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.

Fessler E, Jansen M, De Sousa E Melo F, Zhao L, Prasetyanti PR, Rodermond H, Kandimalla R, Linnekamp JF, Franitza M, van Hooff SR, de Jong JH, Oppeneer SC, van Noesel CJ, Dekker E, Stassi G, Wang X, Medema JP, Vermeulen L.

Oncogene. 2016 Nov 17;35(46):6026-6037. doi: 10.1038/onc.2016.134. Epub 2016 May 9.

7.

HER-3: hub for escape mechanisms.

Capone E, Prasetyanti PR, Sala G.

Aging (Albany NY). 2015 Nov;7(11):899-900. No abstract available.

8.

ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).

Prasetyanti PR, Capone E, Barcaroli D, D'Agostino D, Volpe S, Benfante A, van Hooff S, Iacobelli V, Rossi C, Iacobelli S, Medema JP, De Laurenzi V, Sala G.

Oncotarget. 2015 Jul 10;6(19):16902-11.

9.

Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.

Colak S, Zimberlin CD, Fessler E, Hogdal L, Prasetyanti PR, Grandela CM, Letai A, Medema JP.

Cell Death Differ. 2014 Jul;21(7):1170-7. doi: 10.1038/cdd.2014.37. Epub 2014 Mar 28.

10.

Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colon.

Prasetyanti PR, Zimberlin CD, Bots M, Vermeulen L, Melo Fde S, Medema JP.

Mol Cancer. 2013 Oct 21;12(1):126. doi: 10.1186/1476-4598-12-126.

11.

Isolation and propagation of colon cancer stem cells.

Prasetyanti PR, Zimberlin C, De Sousa E Melo F, Medema JP.

Methods Mol Biol. 2013;1035:247-59. doi: 10.1007/978-1-62703-508-8_21.

PMID:
23959997
12.

A high-throughput functional complementation assay for classification of BRCA1 missense variants.

Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, Pieterse M, Wientjens E, Seibler J, Hogervorst FB, Jonkers J.

Cancer Discov. 2013 Oct;3(10):1142-55. doi: 10.1158/2159-8290.CD-13-0094. Epub 2013 Jul 18.

13.

Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.

Kemper K, Prasetyanti PR, De Lau W, Rodermond H, Clevers H, Medema JP.

Stem Cells. 2012 Nov;30(11):2378-86. doi: 10.1002/stem.1233.

14.

Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients.

de Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR, Fessler E, van den Bergh SP, Rodermond H, Dekker E, van der Loos CM, Pals ST, van de Vijver MJ, Versteeg R, Richel DJ, Vermeulen L, Medema JP.

Cell Stem Cell. 2011 Nov 4;9(5):476-85. doi: 10.1016/j.stem.2011.10.008.

15.

High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumors.

Koudijs MJ, Klijn C, van der Weyden L, Kool J, ten Hoeve J, Sie D, Prasetyanti PR, Schut E, Kas S, Whipp T, Cuppen E, Wessels L, Adams DJ, Jonkers J.

Genome Res. 2011 Dec;21(12):2181-9. doi: 10.1101/gr.112763.110. Epub 2011 Aug 18.

16.

Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.

Fachiroh J, Prasetyanti PR, Paramita DK, Prasetyawati AT, Anggrahini DW, Haryana SM, Middeldorp JM.

J Clin Microbiol. 2008 Apr;46(4):1374-80. doi: 10.1128/JCM.01368-07. Epub 2008 Feb 6.

Supplemental Content

Loading ...
Support Center